In this study, we administrated hNSCs repetitively via an intranasal delivery approach, which were derived from embryos aborted at 6–8 weeks of gestation, to the brains of APP/PS1 transgenic mice who exhibit AD-like pathology at an older age. This evidence concerns the gene PSEN1 and Alzheimer disease.